Antiviral therapy of HCV in the cirrhotic and transplant candidate.

International Journal of Medical Sciences
Steven K Herrine, Victor J Navarro

Abstract

Despite the improved efficacy of peginterferons, the rate of sustained virologic response is suboptimal in cirrhotic patients, relative to non-cirrhotic patients. However, the treatment of patients with compensated cirrhosis has recently been encouraged by expert panels. Interferon-based therapy may provide additional benefit by reducing the risk of hepatocellular carcinoma in cirrhotic patients as suggested in preliminary studies. Results of two ongoing prospective studies are awaited to answer the important question of the effectiveness of suppressive interferon therapy, even in the absence of sustained virologic response. Given the importance of recurrent HCV following liver transplantation, attention has been directed toward the antiviral treatment of patients with advanced liver disease. This approach needs to be pursued with caution given the potential morbidity of the therapy. Recently, a low accelerating dosage regimen has provided excellent results and is the subject of additional inquiry.

References

May 15, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A KasaharaK Okita
May 15, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L SerfatyR Poupon
Sep 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M CharltonJ Hoofnagle
Oct 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T PoynardJ Albrecht
Dec 7, 2000·The New England Journal of Medicine·E J HeathcoteJ De Pamphilis
Apr 20, 2002·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Jeffrey S CrippinMichael R Charlton
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Aug 28, 2003·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Ryan M ThomasDavid H Van Thiel
Oct 31, 2003·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Russell H WiesnerUNKNOWN International Liver Transplantation Society Expert Panel
Apr 2, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Doris B StraderUNKNOWN American Association for the Study of Liver Diseases
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paul J PockrosUNKNOWN PROACTIVE Study Group
Jul 19, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gregory T EversonCatherine Ray

❮ Previous
Next ❯

Citations

Jan 11, 2011·Journal of Vascular Surgery·Massimiliano M Marrocco-TrischittaRoberto Chiesa

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
biopsy

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Expert Opinion on Emerging Drugs
Robert FlisiakAnna Parfieniuk-Kowerda
Acta Medica Croatica : C̆asopis Hravatske Akademije Medicinskih Znanosti
Rajko Ostojić
© 2022 Meta ULC. All rights reserved